Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: A double-blind, placebo-controlled study

American Journal of Psychiatry celebrates 150th anniversary

Andreasen, N. C. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.1 · Cited by 204 · see citing works

The social construction of mental illness

Eisenberg, L. (1988) · Psychological Medicine · doi:10.1017/s0033291700001823 · Cited by 145 · see citing works

The on-off phenomenon.

Lees, A. J. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.suppl.29 · Cited by 125 · see citing works

Verbal learning differences in epileptic patients with left and right temporal lobe foci - a pharmacologically induced phenomenon?

Durwen, H. F., & Elger, C. E. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04066.x · Cited by 48 · see citing works

Preface

(1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb00001.x · Cited by 10 · see citing works

The <i>Movement</i> Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141 · see citing works

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,046 · see citing works

Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling

Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642 · see citing works

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

Funkiewiez, A. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.009803 · Cited by 568 · see citing works

Neuropsychiatric symptoms in Parkinson's disease

Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 320 · see citing works

Behavioural disorders, Parkinson's disease and subthalamic stimulation

Houéto, J. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.701 · Cited by 489 · see citing works

Deep brain stimulation: Neuropsychological and neuropsychiatric issues

Voon, V., Kubu, C. S., Krack, P., Houéto, J., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 402 · see citing works

Nonmotor fluctuations in Parkinson disease

Storch, A., Schneider, C. B., Wolz, M., Stürwald, Y., Nebe, A., Odin, P., Mahler, A., Fuchs, G., Jost, W. H., Chaudhuri, К. R., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318285c0ed · Cited by 373 · see citing works

Motivation, reward, and Parkinson's disease: influence of dopatherapy

Czernecki, V. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00108-2 · Cited by 336 · see citing works

Deep brain stimulation: Preoperative issues

Lang, A. E., Houéto, J., Krack, P., Kubu, C. S., Lyons, K. E., Moro, E., Ondo, W. G., Pahwa, R., Poewe, W. H., Tröster, A. I., et al. (2006) · Movement Disorders · doi:10.1002/mds.20955 · Cited by 306 · see citing works

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease

Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Blercom, N. V., Xie, J., Moro, E., Benabid, A., & Pollak, P. (2003) · Movement Disorders · doi:10.1002/mds.10441 · Cited by 266 · see citing works

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study

Rektorová, I., Rektor, I., Bareš, M., Dostál, V., Ehler, E., Fanfrdlová, Z., Fiedler, J., Klajblová, H., Kulišťák, P., Ressner, P., et al. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00612.x · Cited by 248 · see citing works

Depression in Parkinson's disease - a review

LIEBERMAN, A. N. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00536.x · Cited by 244 · see citing works

Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease

Volkmann, J., Daniels, C., & Witt, K. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.111 · Cited by 232 · see citing works

Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease

Burn, D. J. (2002) · Movement Disorders · doi:10.1002/mds.10114 · Cited by 223 · see citing works

Psychiatric aspects of Parkinson?s disease: An Update

Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200 · see citing works

Behavioral phenotyping of mouse models of Parkinson's disease

Taylor, T. N., Greene, J. G., & Miller, G. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.004 · Cited by 198 · see citing works

Parkinson’s disease and anxiety

Walsh, K., & Bennett, G. A. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.904.89 · Cited by 193 · see citing works

Anxiety in Parkinson’s disease: A critical review of experimental and clinical studies

Prediger, R. D. S., Matheus, F. C., Schwarzbold, M. L., Lima, M. M. S., & Vital, M. A. B. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.039 · Cited by 190 · see citing works

Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits

Carvalho, M. M., Campos, F. L., Coimbra, B., Pêgo, J. M., Rodrigues, C., Lima, R., Rodrigues, A. J., Sousa, N., & Salgado, A. J. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-14 · Cited by 184 · see citing works

The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

Martínez‐Fernández, R., Schmitt, E., Martínez‐Martín, P., & Krack, P. (2016) · Movement Disorders · doi:10.1002/mds.26731 · Cited by 165 · see citing works

Pharmacokinetic Optimisation in the Treatment of Parkinson???s Disease

Nyholm, D. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645020-00001 · Cited by 163 · see citing works

Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus

Vriend, C., Raijmakers, P. G. H. M., Veltman, D. J., van Dijk, K. D., van der Werf, Y. D., Foncke, E. M. J., Smit, J. H., Berendse, H. W., & van den Heuvel, O. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304811 · Cited by 150 · see citing works

Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease

Merims, D., & Giladi, N. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.007 · Cited by 148 · see citing works

Factors affecting the quality of life of patients with idiopathic Parkinson's disease-a cross-sectional study in an outpatient clinic attendees

Sławek, J. W., Derejko, M., & Lass, P. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.04.006 · Cited by 142 · see citing works

Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson

Ardouin, C., Chéreau, I., Llorca, P., Lhommée, E., Durif, F., Pollak, P., & Krack, P. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.06.003 · Cited by 134 · see citing works

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

Albanese, A., Bonuccelli, U., Brefel‐Courbon, C., Chaudhuri, К. R., Colosimo, C., Eichhorn, T. E., Melamed, E., Pollak, P., van Laar, T., & Zappia, M. (2001) · Movement Disorders · doi:10.1002/mds.1069 · Cited by 131 · see citing works

Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of l-DOPA treatment

Jaunarajs, K. L. E., Angoa‐Pérez, M., Kuhn, D. M., & Bishop, C. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.007 · Cited by 129 · see citing works

Subthalamic Stimulation in Parkinson Disease

Houéto, J., Mallet, L., Mesnage, V., du Montcel, S. T., Béhar, C., Gargiulo, M., Torny, F., Pélissolo, A., Welter, M., & Agid, Y. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1090 · Cited by 118 · see citing works

The dopamine transporter: Importance in Parkinson's disease

Nutt, J. G., Carter, J. H., & Sexton, G. J. (2004) · Annals of Neurology · doi:10.1002/ana.20089 · Cited by 118 · see citing works

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study

Hanagasi, H. A., Gurvit, H. I., Unsalan, P., Horozoğlu, H., Tuncer, N., Feyzioğlu, A., Günal, D. İ., Yener, G., Çakmur, R., Sahin, H. A., et al. (2011) · Movement Disorders · doi:10.1002/mds.23738 · Cited by 113 · see citing works

Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear

Falzone, T. L., Gelman, D. M., Young, J. I., Grandy, D. K., Low, M. J., & Rubinstein, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01842.x · Cited by 109 · see citing works

Personality Traits and Striatal Dopamine Synthesis Capacity in Healthy Subjects

Laakso, A., Wallius, E., Kajander, J., Bergman, J. R., Eskola, O., Solin, O. H., Ilonen, T., Salokangas, R. K. R., Syvälahti, E. K. G., & Hietala, J. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.904 · Cited by 108 · see citing works

Depression and impulse control disorders in Parkinson׳s disease: two sides of the same coin?

Vriend, C., Pattij, T., van der Werf, Y. D., Voorn, P., Booij, J., Rutten, S., Berendse, H. W., & van den Heuvel, O. A. (2014) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.001 · Cited by 106 · see citing works

Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study

Smith, K. M., Eyal, E., & Weintraub, D. A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2472 · Cited by 106 · see citing works

Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients

Erro, R., Pappatà, S., Amboni, M., Vicidomini, C., Longo, K., Santangelo, G., Picillo, M., Vitale, C., Moccia, M., Giordano, F., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.05.022 · Cited by 104 · see citing works

Emotional manifestations of PD: Neurobiological basis

Castrioto, A., Thobois, S., Carnicella, S., Maillet, A., & Krack, P. (2016) · Movement Disorders · doi:10.1002/mds.26587 · Cited by 98 · see citing works

Neuropsychiatric Complications of Medical and Surgical Therapies for Parkinson’s Disease

Burn, D. J., & Tröster, A. I. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267466 · Cited by 95 · see citing works

Depression in Parkinson's disease

Burn, D. J. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.9.s3.6.x · Cited by 95 · see citing works

Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease

Funkiewiez, A., Ardouin, C., Cools, R., Krack, P., Fraix, V., Batir, A., Chabardès, S., Benabid, A., Robbins, T., & Pollak, P. (2006) · Movement Disorders · doi:10.1002/mds.21029 · Cited by 103 · see citing works

Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy

Fetoni, V., Soliveri, P., Monza, D., Testa, D., & Girotti, F. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.4.541 · Cited by 88 · see citing works

What a neurologist should know about depression in Parkinson’s disease

Timmer, M. H. M., Beek, M. H. C. T. V., Bloem, B. R., & Esselink, R. A. J. (2017) · Practical Neurology · doi:10.1136/practneurol-2017-001650 · Cited by 87 · see citing works

Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat

Jaunarajs, K. L. E., Dupre, K. B., Ostock, C. Y., Button, T., Terrence Deak, B., & Bishop, C. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e80 · Cited by 87 · see citing works

Deep brain stimulation of the subthalamic nucleus in Parkinson's Disease 1993 – 2003: where are we 10 years on?

Ashkan, K., Wallace, B. A., Bell, B., & Benabid, A. (2004) · British Journal of Neurosurgery · doi:10.1080/02688690410001660427 · Cited by 84 · see citing works

Emotional dysfunction in Parkinson's disease.

Blonder, L. X., & Slevin, J. T. (2011) · PubMed Central · doi:10.3233/ben-2011-0329 · Cited by 83 · see citing works

Interactions between deep brain stimulation and levodopa in Parkinson’s disease

Nutt, J. G., Rufener, S. L., Carter, J. H., Anderson, V. C., Pahwa, R., Hammerstad, J. P., & Burchiel, K. J. (2001) · Neurology · doi:10.1212/wnl.57.10.1835 · Cited by 82 · see citing works

Relationship Between Mood and Motor Fluctuations in Parkinson's Disease

Richard, I. H., Justus, A. W., & Kurlan, R. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.1.35 · Cited by 81 · see citing works

Dopaminergic Mechanisms Underlying Normal Variation in Trait Anxiety

Berry, A. S., White, R. L., Furman, D. J., Naskolnakorn, J., Shah, V. D., D'Esposito, M., & Jagust, W. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2382-18.2019 · Cited by 50 · see citing works

Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease

Rektorová, I., Baláž, M., Svátová, J., Zárubová, K., Honig, I., Dostal, V., Sedláčková, S., Nestrašil, I., Mastík, J., Bareš, M., et al. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31815d25ce · Cited by 77 · see citing works

Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study

Kulisevsky, J., Pascual-Sedano, B., Barbanoj, M., Gironell, A., Pagonabarraga, J., & García-Sánchez, C. (2007) · Movement Disorders · doi:10.1002/mds.21205 · Cited by 77 · see citing works

Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease

BLACK, K. J., Hershey, T. G., Hartlein, J. M., Carl, J. L., & Perlmutter, J. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300632 · Cited by 75 · see citing works

The longitudinal impact of depression on disability in Parkinson disease

Pontone, G. M., Bakker, C. C., Chen, S., Mari, Z. K., Marsh, L., Rabins, P. V., Williams, J. R., & Bassett, S. S. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4350 · Cited by 72 · see citing works

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease

Delpont, B., Lhommée, E., Klinger, H., Schmitt, E., Bichon, A., Fraix, V., Castrioto, A., Quésada, J.-L., Pélissier, P., Kistner, A., et al. (2017) · Movement Disorders · doi:10.1002/mds.27101 · Cited by 72 · see citing works

Dopaminergic Therapies for Non-motor Symptoms in Parkinson’s Disease

Schaeffer, E., & Berg, D. (2017) · CNS Drugs · doi:10.1007/s40263-017-0450-z · Cited by 69 · see citing works

Differential Effects of L-Dopa and Subthalamic Stimulation on Depressive Symptoms and Hedonic Tone in Parkinson's Disease

Witt, K., Daniels, C., Herzog, J., Lorenz, D., Volkmann, J., Reiff, J., Mehdorn, H. M., Deuschl, G., & Krack, P. (2006) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18.3.397 · Cited by 68 · see citing works

Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test

Fabbri, M., Coelho, M. M., Guedes, L. C., Chendo, I., Sousa, A. C., Rosa, M. M., Abreu, D., Costa, N., Godinho, C., Antonini, A., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.007 · Cited by 67 · see citing works

Neuropsychiatric aspects of parkinson’s disease

Aarsland, D., & Karlsen, K. (1999) · Current Psychiatry Reports · doi:10.1007/s11920-999-0011-3 · Cited by 65 · see citing works

Effect of Attentional Focus Instructions on Motor Learning and Performance of Patients with Central Nervous System and Musculoskeletal Disorders: a Systematic Review

Piccoli, A., Rossettini, G., Cecchetto, S., Viceconti, A., Ristori, D., Turolla, A., Maselli, F., & Testa, M. (2018) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk3030040 · Cited by 63 · see citing works

Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background

Yamamoto, M. (2001) · Journal of Neurology · doi:10.1007/pl00022917 · Cited by 64 · see citing works

Recognition and management of neuropsychiatric complications in Parkinson's disease

Ferreri, F., Agbokou, C., & Gauthier, S. G. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060542 · Cited by 63 · see citing works

Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease

Racette, B. A., Hartlein, J. M., Hershey, T. G., Mink, J. W., Perlmutter, J. S., & BLACK, K. J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.4.438 · Cited by 63 · see citing works

Treatment options for depression and psychosis in Parkinson's disease

Poewe, W. H., & Seppi, K. (2001) · Journal of Neurology · doi:10.1007/pl00007821 · Cited by 59 · see citing works

Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion

Isacson, D. G. L., Bingefors, K., Kristiansen, I. S., & Nyholm, D. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01049.x · Cited by 58 · see citing works

Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: From history to the interaction with the monoaminergic systems

Faggiani, E., & Benazzouz, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.003 · Cited by 57 · see citing works

Depression in Parkinsonʼs disease

Brooks, D. J., & Doder, M. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00006 · Cited by 57 · see citing works

Changing Gears – DBS For Dopaminergic Desensitization in Parkinson's Disease?

Weiß, D., Volkmann, J., Fasano, A. A., Kühn, A. A., Krack, P., & Deuschl, G. (2021) · Annals of Neurology · doi:10.1002/ana.26164 · Cited by 53 · see citing works

Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial.

Ghielen, I., van Wegen, E. E. H., Rutten, S., de Goede, C. J. T., Houniet-de Gier, M., Collette, E. H., Burgers-Bots, I. A. L., Twisk, J. W. R., Kwakkel, G., Vermunt, K., et al. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.09.008 · Cited by 50 · see citing works

Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward

Evans, A. H., Lawrence, A. D., Cresswell, S. A., Katzenschlager, R., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.22898 · Cited by 51 · see citing works

Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study☆☆Supplementary

Bearn, J., Evans, A. H., Kelleher, M., Turner, K., & Lees, A. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.06.005 · Cited by 52 · see citing works

Non-Motor Aspects of Parkinson's Disease

Borek, L. L., Amick, M. M., & Friedman, J. H. (2006) · CNS Spectrums · doi:10.1017/s1092852900013560 · Cited by 51 · see citing works

Serotonin transporter binding and anxiety symptoms in Parkinson’s disease

Joling, M., van den Heuvel, O. A., Berendse, H. W., Booij, J., & Vriend, C. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316193 · Cited by 50 · see citing works

Duodenal levodopa infusion for the treatment of Parkinson’s disease

Samanta, J., & Hauser, R. A. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.5.657 · Cited by 48 · see citing works

Balance problems with Parkinson's disease: are they anxiety-dependent?

Pasman, E. P., Murnaghan, C. D., Bloem, B. R., & Carpenter, M. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.050 · Cited by 47 · see citing works

Correlation between Tapping and Inserting of Pegs in Parkinson's Disease

Müller, T. H., Schafer, S. L., Kuhn, W., & Przuntek, H. (2000) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001062 · Cited by 47 · see citing works

Psychostimulant effect of levodopa: reversing sensitisation is possible

Castrioto, A., Kistner, A., Klinger, H., Lhommée, E., Schmitt, E., Fraix, V., Chabardès, S., Mertens, P., Quesada, J., Broussolle, E., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302444 · Cited by 42 · see citing works

Anxiety disorders in Parkinson's disease

Marsh, L. (2000) · International Review of Psychiatry · doi:10.1080/09540260020002532 · Cited by 45 · see citing works

Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson׳s disease

Shin, K. S., Zhao, T., Choi, H. S., Hwang, B. Y., Lee, C. K., & Lee, M. K. (2014) · Brain Research · doi:10.1016/j.brainres.2014.04.015 · Cited by 44 · see citing works

The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation

Faggiani, E., Delaville, C., & Benazzouz, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.010 · Cited by 43 · see citing works

Nonmotor Fluctuations in Parkinson's Disease.

Franke, C., & Storch, A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.021 · Cited by 54 · see citing works

A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability

Schneider, R. B., Auinger, P., Tarolli, C. G., Iourinets, J., Gil-Díaz, M. C., & Richard, I. H. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.020 · Cited by 39 · see citing works

Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial

Ciesielska, A., Samaranch, L., Sebastián, W. S., Dickson, D. W., Goldman, S. M., Forsayeth, J., & Bankiewicz, K. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169965 · Cited by 39 · see citing works

The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease

Jazaeri, S. Z., Azad, A., Mehdizadeh, H., Habibi, S. A., Najafabadi, M. M., Saberi, Z. S., Rahimzadegan, H., Moradi, S., Behzadipour, S., Parnianpour, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192168 · Cited by 38 · see citing works

Medical treatment of Parkinson’s disease

Fahn, S. (1998) · Journal of Neurology · doi:10.1007/pl00007742 · Cited by 38 · see citing works

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease

Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 37 · see citing works

Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory–perceptual processing while walking

Martens, K. A. E., Ellard, C. G., & Almeida, Q. J. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.05.015 · Cited by 36 · see citing works

Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care

Taylor, J., Anderson, W. S., Brandt, J., Mari, Z. K., & Pontone, G. M. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.08.017 · Cited by 36 · see citing works

Anxiety‐provoked gait changes are selectively dopa‐responsive in Parkinson's disease

Martens, K. A. E., Ellard, C. G., & Almeida, Q. J. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12928 · Cited by 36 · see citing works

Pharmacologic Treatment of Anxiety Disorders in Parkinson Disease

Pontone, G. M., Williams, J. R., Anderson, K. E., Chase, G. A., Goldstein, S. R., Grill, S. E., Hirsch, E. S., Lehmann, S. W., Little, J. T., Margolis, R. L., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.023 · Cited by 36 · see citing works

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues

Claßen, J., Koschel, J., Oehlwein, C., Seppi, K., Urban, P. P., Winkler, C., Wüllner, U., & Storch, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1757-0 · Cited by 34 · see citing works

Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease

Carvalho, M. M., Campos, F. L., Marques, M., Soares‐Cunha, C., Kokras, N., Dalla, C., Leite‐Almeida, H., Sousa, N., & Salgado, A. J. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00145 · Cited by 35 · see citing works

Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies

Lai, T. T., Gericke, B., Feja, M., Conoscenti, M. A., Zelikowsky, M., & Richter, F. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00547-4 · Cited by 32 · see citing works

Management of behavioral and psychiatric problems in Parkinson's disease

Rabinstein, A. A., & Shulman, L. M. (2000) · Parkinsonism &amp; Related Disorders · doi:10.1016/s1353-8020(00)00039-0 · Cited by 30 · see citing works

Maladie de Parkinson : de la physiopathologie des troubles psychiques à la maîtrise du traitement dopaminergique

Thobois, S., Ardouin, C., Schmitt, E., Lhommée, E., Klinger, H., Xie, J., Lagrange, C., Kistner, A., Kombo, M. A., Fleury, V., et al. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.006 · Cited by 28 · see citing works

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats

Sgroi, S., Kaelin‐Lang, A., & Capper-Loup, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00331 · Cited by 28 · see citing works

Behavioral disturbances in Parkinson's disease

Anderson, K. E. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.3/kanderson · Cited by 27 · see citing works

Clinical risk–benefit assessment of dopamine agonists

Möller, J. C., Eggert, K. M., Unger, M. M., Odin, P., Chaudhuri, К. R., & Oertel, W. H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02214.x · Cited by 27 · see citing works

Dopamine D1Agonist Activates Temporal Lobe Structures in Primates

BLACK, K. J., Hershey, T. G., Gado, M. H., & Perlmutter, J. S. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.84.1.549 · Cited by 24 · see citing works

Phenomenology of Atypical Anxiety Disorders in Parkinson's Disease: A Systematic Review

Dissanayaka, N. N., Forbes, E. J., Perepezko, K. M., Leentjens, A. F. G., Dobkin, R. D., Dujardin, K., & Pontone, G. M. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.02.004 · Cited by 23 · see citing works

The Human Experience with Intravenous Levodopa

Siddiqi, S., Abraham, N., Geiger, C. L., Karimi, M., Perlmutter, J. S., & BLACK, K. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00307 · Cited by 22 · see citing works

Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment

Stefanova, N., Seppi, K., Scherfler, C., Puschban, Z., & Wenning, G. K. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_23 · Cited by 22 · see citing works

Neuroradiology

Bull, J. W. D. (1967) · BMJ · doi:10.1136/bmj.4.5581.731

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings

Maricle, R. A., Nutt, J. G., & Carter, J. H. (1995) · Movement Disorders · doi:10.1002/mds.870100316 · Cited by 88 · see citing works

Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study

Kulisevsky, J., Pascual-Sedano, B., Barbanoj, M., Gironell, A., Pagonabarraga, J., & García-Sánchez, C. (2007) · Movement Disorders · doi:10.1002/mds.21205 · Cited by 77 · see citing works

Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration

Richard, I. H., Frank, S., LaDonna, K. A., Wang, H., McDermott, M., & Kurlan, R. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a791 · Cited by 7 · see citing works

Mood response to levodopa infusion in early Parkinson's disease.

Maricle, R. A., Valentine, R. J., Carter, J., & Nutt, J. G. (1998) · Neurology · doi:10.1212/wnl.50.6.1890 · Cited by 44 · see citing works